A. Definitions and Administration
- Parenteral Nutrition: provision of nutrients via a non-gastrointestinal (GI) route
- Total Parenteral Nutrition (TPN): nutritionally complete diet via a parenteral route
- Routes of Administration: Peripheral and Central
- Peripheral Vein
- Prolonged infusion of hyperosmolar solutions leading to thrombophlebitis
- Adult limit is 650 mOsm/L
- Unless a fairly large (such as "midline") vein is canulated, restricted to 5% glucose
- Central Venous Line
- High flow dilutes hyperosmolar solution (superior vena cava dilution ~ 1:1000)
- Percutaneous cannulation of subclavian vein usually preferred by patient
- Enteral nutrition should be used rather than TPN in inpatients with functional GI tracts [2]
B. Protein
- Critical Role of Proteins in Severely Ill Patients
- Stress associated with increased protein turnover (catabolism)
- Also associated with negative nitrogen balance
- Skeletal muscle function comprised by protein breakdown
- Respiratory muscle weakness leads to increased problems and complications
- High levels of APR especially TNFa are likely etiologies
- Treatment of critically ill adults with recombinant human growth hormone to reverse these catablic effects has lead to 1.9-2.4 fold increased mortality [5]
- Enteral: intestinal hydrolysis to free amino acids, liver uptake. Adults: 0.43g/kg/day
- Parenteral: crystalline L-amino acids into systemic circulation. Adults: <0.8g/kg/day
- Essential Amino Acids: Lys, Trp, Phe, Met, Thr, Leu, Ile, Val
- Nonessential: Ala, Arg, Asp, Cys, Glu, Gly, His, Pro, Ser, Tyr
- Nitrogen Balance
- Dietary protein degraded to amino acids, deaminated, producing amines, ammonia, urea
- Carboxylic acid byproducts used in energy metabolism
- Nitrogen balance depends on nitrogen intake and energy intake.
- If energy requirements are met, use amino acids only for nitrogen requirements
- Additional glutamine may provide some benefits including more rapid recoveries
C. Energy Sources
- Sources of Energy: Summary
- Glucose (carbohydrate)
- Fat
- Protein
- Glucose (Dextrose)
- High biologic utility
- Inexpensive
- Caution with glucose intolerance, hyperosmolar states
- Will increase acid production with increased CO2 load
- Control of glucose levels associated with improved outcomes in intensive care unit (ICU) [9]
- Fat
- Isotonic, low CO2 load, high caloric density
- Expensive
- Platelet adhesion decreased
- Pulmonary vascular resistance increased
- Increased risk of intrahepatic cholestasis (may be progressive) [7]
- Hypertriglyceridemia can precipitate pancreatitis
- 10% and 20% fat emulsions (1.1 and 2.0 kcal/mL)
- 1.2% egg phospholipids and 2.5% glycerin in water
- Glucose infusions increase insulin and thereby suppresses lipolysis
- Therefore, if giving large quantities of dextrose, need to supplement lipids
- Otherwise, insulin will decrease lipolysis and lower secretion of fats leading to fatty acid deficiency
- Increased exogenous insulin administration is associated with increased death in ICU patients [9]
- However, good glucose control is associated with reduced death in ICU [9]
- Protein
- Essential
- Poor hepatic tolerance, increase NH4 leading to encephalopathy
- Renal intolerance with increasing BUN
D. Adult Energy and Cofactor Requirements
- Basal Energy Expenditure (BEE) in KCals/day
- Male BEE = 66.5 + 13.8x(Ideal Kg wt) + (cm height) - 6.8x(age in years)
- Female BEE = 655.1 + 9.6x(Ideal Kg wt) + 1.8x(cm height) - 4.7x(age in years)
- Total energy requirement depends on BEE and Metabolic Activity Factor (MAF)
- MAF varies from 1.0 (normal) to 1.6 for elective surgery to 2.7 with 70% burns
- Electrolytes
- NaCl or NaOAc 60-120mEq
- KCl or KOAc or KPi 75-150 mEq
- Chloride as KCl or NaCl 80-120 mEq
- Mg, Ca also
- Acetate (Na or K): bicarbonate precursor, more stable in TPN; prevents acidosis
- Phosphate (Na or K): required for normal anabolism, along with K and Mg
- Vitamins
- Fat soluble: A, D, and E
- Vitamin C (Ascorbic Acid)
- Folacin
- B complex: Thiamin, Riboflavin, Niacin, Pyridoxine (B6), Cyanocobalamin (B12)
- Pantothenic Acid and Biotin
- Trace Elements
- Zinc and Copper
- Chromium and Manganese
- Selenium
- Glutamine enriched solutions are being evaluated
COMPLICATIONS OF PARENTERAL NUTRIATION |
A. Catheter Related- Overall rate is ~10%; major problems ~2%
- Any anatomic structure between ears and diaphragm may be injured by central line
B. Metabolic
- These are usually iatrogenic
- Minimize by careful monitoring
- Deficiencies, usually of intracellular ions K+, Mg2+, phosphate and essential fatty acids
- Excesses of fluids, major extracellular ions (Na, Cl), glucose and ammonia
- Others: acid/base disturbances, liver enzyme elevations, other deficiencies
- Cholestasis [7]
- Cholestatic liver disease occurs in 15-85% of patients on prolonged TPN
- Longer duration of therapy is major risk factor
- Cholestasis may progress to fibrosis and cirrhosis
- May contribute to ~20% of deaths in patients on long term TPN
- Parenteral intake of omega-6 rich long-chain triglycerides lipid emulsion may reduce risk
- Metronidazole may improve TPN-induced cholestasis, especially in Crohn's Disease patients
C. Infections
- Catheter sepsis: Staphylococcus aureas and epidermidis, Candida ssp, G negative bacteria
- Contamination of solutions: especially Tinea versicolor (fungus)
- Increased risk of C. difficile diarrhea with enteral feedings, particularly post-pyloric [4]
INDICATIONS FOR PARENTERAL NUTRITION |
A. Requirements for Normal Enteric Alimentation- Access:
- Oral
- Nasogastric
- Naso-duodenal
- Feeding Gastrostomy / Jejunostomy
- Peristalsis
- Gastric Emptying
- Intestinal Motility
- Digestion
- Pancreatic Enzymes
- Mucosal Enzymes (Disaccharidases, Enterokinase)
- Absorption
- Micelle formation
- Jejunal Surface area
- Portal Vein (nutrients) and Lymphatics (Fats)
- In patients with functional GI tracts, enteral nutrition is prefered over TPN [2]
B. Patient Selection
- Do not use parenteral nutrition when the gut is functioning
- Use only if nutritional needs not met by external route
- Established (proven) benefit
- Patients unable to eat or absorb nutrients for extended period
- neurological deficits
- short bowel syndrome
- premature infants
- oropharyngeal dysfunction
- Normal patients who cannot eat for more than 10-14 days
- Severely malnourished patients undergoing major elective surgery
- Patients with major trauma, head trauma, burns
- Bone marrow transplant recipients undergoing intensive chemotherapy
- No clear improvement in mortality overall with use of TPN [3]
- Clearly improves morbidity in malnourished patients [3]
- Enteral (tube feeding) nutrition is not beneficial in patients with dementia [6]
- Benefits of Parenteral Nutrition Unproven
- GI fistulas and other GI dysfunction (pancreatitis)
- May induce remission in Crohn Disease
- Acute renal failure, hepatic failure
- AIDS - particularly wasting syndrome
- Cancer patients with neoplasm associated wasting
- Critically ill patients - medical intensive care unit (non-trauma)
- Patients with high chronic levels of stress response proteins may not benefit
- In patients with gastrointestinal cancer post-surgery, early enteral nutrition reduces post-operative stay and complication rate, compared with parenteral nutrition [8]
C. Definition of Starvation
- >10% weight loss in 6 months
- Albumin < 3.5 g/dL
- Total lymphocyte count <1500.
D. Weaning off of TPN
- TPN is temporary support measure with nearly all cases will be weaned off
- Reduce TPN to 50% of calculated needs when patient resumes eating
- Continue decreasing (weaning) as patient's oral/enteral intake increased
- This helps to "re-train" the GI tract
References
- Souba WW. 1997. NEJM. 336(1):41
- Zaloga GP. 2006. Lancet. 367(9516):1101
- Heyland DK, MacDOnald S, Keefe L, Drover JW. 1998. JAMA. 280(23):2013
- Bliss DZ, Johnson S, Savik K, et al. 1998. Ann Intern Med. 129(12):1012
- Takala J, Ruokonen E, Webster NR, et al. 1999. NEJM. 341(11):785
- Finucane TE, Christmas C, Travis K. 1999. NEJM. 282(14):1365
- Cavicchi M, Beau P, Crenn P, et al. 2000. Ann Intern Med. 132(7):525
- Bozzetti F, Braga M, Gianotti L, et al. 2001. Lancet. 358(9292):1487
- Finney SJ, Zekveld C, Elia A, Evans TW. 2003. JAMA. 290(15):2041